DanCann Pharma A/S: Germany trends – prescriptions for medicinal cannabis positively influenced by new legalization
COPENHAGEN, Denmark, 14 June 2024 - DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the "Company"), a Danish company powered by cannabinoids, announces key insights into the recent legalization of cannabis in Germany ("CanG"), which came into effect on April 1, 2024.Key highlights from CanG: · Declassification: Cannabis is no longer classified as a narcotic but as a regular (off-label-use) medicine. · Elimination of risk assessment: No longer required to assess risks such as possible addiction when prescribing medicinal cannabis. · Simplified prescription process: Abolition